{
    "nct_id": "NCT04605211",
    "official_title": "Being Present-MPN: A Distress Reduction Intervention for Patients With BCR-ABL-Negative MPNs and CML on Tyrosine Kinase Inhibitors",
    "inclusion_criteria": "* PATIENT: Carry a diagnosis of BCR-ABL-negative MPN or CML\n* PATIENT: Have an estimated life expectancy of at least 6 months, assessed by principal investigator or treating investigator\n* PATIENT: Be able to speak and read English\n* PATIENT: Be able to navigate websites, fill out forms on the web, communicate by email, and have regular access to the internet (assessed by participant self-report)\n* PATIENT: Have daily access to a mobile phone capable of receiving text messages, as determined by a study investigator\n* PATIENT: Be able to provide informed consent\n* CAREGIVER: Be a spouse/partner, other family member, or a close friend of a BCR-ABL-negative patient who consented to participate in the Being Present-MPN study\n* CAREGIVER: Be able to speak and read English\n* CAREGIVER: Be able to navigate websites, fill out forms on the web, communicate by email, and have regular access to the internet (assessed by participant self-report)\n* CAREGIVER: Have access to a mobile phone capable of receiving text messages, as determined by a study investigator\n* CAREGIVER: Be able to provide informed consent\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* PATIENT: Have had their BCR-ABL-negative MPN transform into acute leukemia\n* PATIENT: Have had their CP-CML transform into blast phase\n* PATIENT: Be post-allogeneic stem cell transplantation\n* PATIENT AND CAREGIVER: Have extensive hearing loss such that ability to participate in the study would be impaired",
    "miscellaneous_criteria": ""
}